Background: Aboriginal and Torres Strait Islander people experience a greater burden of disease and die younger than non-Indigenous Australians, with Aboriginal people living in remote areas of the Northern Territory of Australia having the lowest life expectancy estimates. Despite a high burden of chronic disease among Aboriginal and Torres Strait Islander people, access to specialist health services remains low and models of care that increase engagement, may improve health outcomes. Methods: We describe client and staff perspectives of a model of clinical genetics services provided by the MJD Foundation (MJDF) in geographically and culturally complex contexts within the Northern Territory of Australia. We seek to understand the MJDF m...
[Extract] Biobanks are collections of biological specimens, with accompanying health and demographic...
Expanded carrier screening (ECS) for recessive monogenic diseases requires prior knowledge of genomi...
(1) Background: Genomic precision medicine (PM) utilises people’s genomic data to inform the deliver...
Background: Aboriginal and Torres Strait Islander people experience a greater burden of disease and ...
Background: Aboriginal and Torres Strait Islander people do not enjoy equal access to specialist hea...
Abstract Background Aboriginal and Torres Strait Islander people do not enjoy equal access to specia...
BACKGROUND: Aboriginal and Torres Strait Islander people do not enjoy equal access to specialist hea...
© Springer International Publishing AG 2017. Advances in our understanding of genetic and rare disea...
Personalised medicine is a newly emerging field with much to offer to all populations in improved cl...
Indigenous populations are thought to have particularly low levels of access to genetic health servi...
Genomics is increasingly becoming an integral component of health research and clinical care. The pe...
Australian Aborigines have much higher rates of illness and life expectancy, up to 20 years lower th...
Expanded carrier screening (ECS) for recessive monogenic diseases requires prior knowledge of genomi...
Advances in omics and specifically genomic technologies are increasingly transforming rare disease d...
Expanded carrier screening (ECS) for recessive monogenic diseases requires prior knowledge of genomi...
[Extract] Biobanks are collections of biological specimens, with accompanying health and demographic...
Expanded carrier screening (ECS) for recessive monogenic diseases requires prior knowledge of genomi...
(1) Background: Genomic precision medicine (PM) utilises people’s genomic data to inform the deliver...
Background: Aboriginal and Torres Strait Islander people experience a greater burden of disease and ...
Background: Aboriginal and Torres Strait Islander people do not enjoy equal access to specialist hea...
Abstract Background Aboriginal and Torres Strait Islander people do not enjoy equal access to specia...
BACKGROUND: Aboriginal and Torres Strait Islander people do not enjoy equal access to specialist hea...
© Springer International Publishing AG 2017. Advances in our understanding of genetic and rare disea...
Personalised medicine is a newly emerging field with much to offer to all populations in improved cl...
Indigenous populations are thought to have particularly low levels of access to genetic health servi...
Genomics is increasingly becoming an integral component of health research and clinical care. The pe...
Australian Aborigines have much higher rates of illness and life expectancy, up to 20 years lower th...
Expanded carrier screening (ECS) for recessive monogenic diseases requires prior knowledge of genomi...
Advances in omics and specifically genomic technologies are increasingly transforming rare disease d...
Expanded carrier screening (ECS) for recessive monogenic diseases requires prior knowledge of genomi...
[Extract] Biobanks are collections of biological specimens, with accompanying health and demographic...
Expanded carrier screening (ECS) for recessive monogenic diseases requires prior knowledge of genomi...
(1) Background: Genomic precision medicine (PM) utilises people’s genomic data to inform the deliver...